Dialysis patients' symptoms often ignored – new trial aims to change that
NCT ID NCT06257134
First seen Feb 23, 2026 · Last updated Jun 23, 2026 · Updated 22 times
Summary
This study tests whether having dialysis patients regularly report their symptoms electronically, and automatically alerting their care teams to severe symptoms, can improve their quality of life. Over 2,200 adults on dialysis in France will take part. The goal is to see if this simple monitoring approach leads to better symptom management and a better daily life for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ALTIR
RECRUITINGVandœuvre-lès-Nancy, 54 500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHRU Nancy
RECRUITINGVandœuvre-lès-Nancy, 54500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Maison du Rein AURAD Aquitaine
NOT_YET_RECRUITINGGradignan, 33171, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
systematic symptom monitoring with feedback to healthcare teams
What this could lead to
If it works, this could lead to better symptom management and improved quality of life for dialysis patients, and show that routine symptom tracking is feasible and cost-effective.
What could go wrong
This is a large trial, but it's testing a monitoring process, not a new drug. The effect may be small, and improvements in quality of life are not guaranteed. Results may not apply to all dialysis settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.